SS Innovations International, Inc. filed a Form 8-K on November 13, 2026, disclosing the appointment of Gary G. Lo as Chief Financial Officer and the promotion of Dr. Vishwajyoti P. Srivastava as President, both effective November 6, 2026.

Key Highlights

  • New CFO appointed: Gary G. Lo, age 56, joined SS Innovations International as Chief Financial Officer effective November 6, 2026, based in the United States.
  • Base salary: Mr. Lo's employment agreement provides for annual base compensation of $400,000, with a target annual cash bonus of 50% of base salary.
  • Stock option grant: Mr. Lo is to receive options to purchase 500,000 shares of common stock at an exercise price of $2.11 per share, vesting in four annual installments starting on the first anniversary of the effective date.
  • Severance terms: If terminated without cause before the first anniversary of the effective date, Mr. Lo is eligible for three months of base salary; on or after that anniversary, six months of base salary.
  • New President named: Dr. Vishwajyoti P. Srivastava, previously serving as Chief Executive Officer - Asia Pacific, was appointed President effective November 6, 2026, and has relocated to Denver, Colorado.
  • Salary increase for Dr. Srivastava: The Board of Directors authorized an increase in Dr. Srivastava's base salary to $500,000 in connection with his appointment and relocation.
  • Family relationship disclosed: According to the filing, Dr. Vishwajyoti P. Srivastava is the son of Dr. Sudhir Srivastava, the Company's Chairman and Chief Executive Officer.

Leadership Changes at SS Innovations International as of November 6, 2026

According to the Form 8-K filed by SS Innovations International, Inc. (NASDAQ:SSII) on November 13, 2026, the company made two executive appointments effective November 6, 2026. Gary G. Lo joined as Chief Financial Officer under an at-will employment agreement providing for a $400,000 annual base salary. Mr. Lo, described in the filing as having "more than three decades of financial and executive leadership experience across medical technology, healthcare, robotics, enterprise software and global technology businesses," holds an MBA from the University of Chicago Booth School of Business and a Bachelor of Science in Accounting, magna cum laude, from Boston College, and is a CPA.

The filing details Mr. Lo's prior roles, including CFO of Subsense, Inc. from January 2026 to March 2026, CFO of Beyeonics Vision from March 2025 to December 2025, and Vice President of Finance and subsequently CFO of Cellares Corporation from January 2022 to July 2024, where he led a $255 million Series C financing in August 2023. Earlier positions included roles at Legrand, Sparta Systems, 1WorldSync, Johnson and Johnson, Siebel Systems, Boston Scientific, and PwC. His stock options expire ten years from the November 6, 2026 effective date and are granted under the company's 2026 Incentive Stock Plan.

Separately, the filing disclosed that Dr. Vishwajyoti P. Srivastava was elevated from Chief Executive Officer - Asia Pacific to President. In his new role, the filing states, he "will oversee and coordinate the Company's efforts to obtain regulatory approval to market its SSi Mantra robotic surgical system in the United States and the European Union." The company disclosed that a new employment agreement for Dr. Srivastava is still being negotiated and will be filed in a future Form 8-K upon completion. The filing also noted that Dr. Srivastava is the son of Chairman and CEO Dr. Sudhir Srivastava and that no other family relationships exist among the company's executive officers and directors.

What Was Disclosed

SS Innovations International reported the appointment of Gary G. Lo as CFO and promotion of Dr. Vishwajyoti P. Srivastava to President, both effective November 6, 2026, along with their respective compensation terms and a disclosed family relationship between Dr. Srivastava and the company's Chairman and CEO.